World Asset Management Inc Buys 126 Shares of Masimo Corporation (MASI)
World Asset Management Inc increased its position in Masimo Corporation (NASDAQ:MASI) by 4.6% during the second quarter, Holdings Channel reports. The firm owned 2,853 shares of the medical equipment provider’s stock after buying an additional 126 shares during the period. World Asset Management Inc’s holdings in Masimo Corporation were worth $260,000 as of its most recent SEC filing.
Several other hedge funds also recently modified their holdings of MASI. Legato Capital Management LLC increased its stake in shares of Masimo Corporation by 6,238.2% in the first quarter. Legato Capital Management LLC now owns 115,736 shares of the medical equipment provider’s stock worth $1,241,000 after buying an additional 113,910 shares during the period. Retirement Systems of Alabama bought a new stake in shares of Masimo Corporation during the first quarter worth about $5,403,000. Nationwide Fund Advisors increased its stake in shares of Masimo Corporation by 25.8% in the first quarter. Nationwide Fund Advisors now owns 324,526 shares of the medical equipment provider’s stock worth $30,265,000 after buying an additional 66,524 shares during the period. Personal Capital Advisors Corp bought a new stake in shares of Masimo Corporation during the first quarter worth about $234,000. Finally, ProShare Advisors LLC increased its stake in shares of Masimo Corporation by 11.5% in the first quarter. ProShare Advisors LLC now owns 8,418 shares of the medical equipment provider’s stock worth $785,000 after buying an additional 870 shares during the period. 84.14% of the stock is owned by institutional investors and hedge funds.
Masimo Corporation (MASI) opened at 87.25 on Friday. Masimo Corporation has a 12-month low of $53.78 and a 12-month high of $104.71. The stock has a market capitalization of $4.53 billion, a PE ratio of 14.30 and a beta of 0.80. The stock’s 50 day moving average price is $91.42 and its 200-day moving average price is $90.25.
Masimo Corporation (NASDAQ:MASI) last released its earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.71 by $0.12. The firm had revenue of $192.90 million during the quarter, compared to analyst estimates of $189.03 million. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. The business’s quarterly revenue was up 11.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.57 earnings per share. Analysts expect that Masimo Corporation will post $2.80 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: This story was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/08/18/world-asset-management-inc-buys-126-shares-of-masimo-corporation-masi.html.
MASI has been the subject of a number of recent research reports. Zacks Investment Research downgraded Masimo Corporation from a “strong-buy” rating to a “hold” rating in a research note on Thursday, May 11th. Wedbush reaffirmed an “outperform” rating and issued a $112.00 target price on shares of Masimo Corporation in a research note on Monday, May 22nd. BidaskClub downgraded Masimo Corporation from a “buy” rating to a “hold” rating in a research note on Wednesday, July 5th. Stifel Nicolaus assumed coverage on Masimo Corporation in a report on Monday, July 10th. They set a “buy” rating and a $105.00 price target for the company. Finally, Roth Capital increased their price target on Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, July 19th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and four have given a buy rating to the company’s stock. Masimo Corporation currently has an average rating of “Hold” and an average target price of $95.00.
In related news, insider Jon Coleman sold 25,000 shares of the company’s stock in a transaction on Thursday, July 20th. The stock was sold at an average price of $97.50, for a total value of $2,437,500.00. Following the completion of the transaction, the insider now directly owns 32,201 shares in the company, valued at $3,139,597.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Sanford Fitch sold 6,000 shares of the company’s stock in a transaction on Thursday, July 13th. The shares were sold at an average price of $91.89, for a total value of $551,340.00. Following the completion of the transaction, the director now owns 89,249 shares of the company’s stock, valued at $8,201,090.61. The disclosure for this sale can be found here. Insiders sold 115,000 shares of company stock valued at $10,773,180 over the last quarter. Insiders own 16.60% of the company’s stock.
About Masimo Corporation
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI).
Receive News & Stock Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related stocks with our FREE daily email newsletter.